The FDA’s Center for Drug Evaluation and Research (CDER) is responsible for evaluating new drugs before they can be sold. This involves a rigorous review process that includes preclinical toxicology studies, clinical trials, and post-market surveillance. The goal is to ensure that drugs are both safe and effective for their intended use.
